These coinciding results, gene expression and calcium handling, suggest that ANG II treatment leads to conduction interruptions evident in the increased occurrences of EADs and arrhythmias in ANG II treated tissues relative to untreated tissues which may contribute to cardiac dysfunction. The gene discussed is AGT; the disease is cardiac arrhythmia.